Application 213757
- Type
- ANDA
- Sponsor
- AKORN INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | SPRAY, METERED;NASAL | 0.665MG/SPRAY | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50383-943 | Olopatadine Hydrochloride | Olopatadine Hydrochloride Nasal | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |
| 50383-943 | Olopatadine Hydrochloride | Olopatadine Hydrochloride Nasal | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |
| 50383-943 | Olopatadine Hydrochloride | Olopatadine Hydrochloride Nasal | Akorn | ANDA | Current |
| 50383-943 | Olopatadine Hydrochloride | Olopatadine Hydrochloride Nasal | Akorn | ANDA | Current |
| 50383-943 | Olopatadine Hydrochloride | Olopatadine Hydrochloride Nasal | Hi-Tech Pharmacal Co., Inc. | ANDA | Current |